Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3441]
News [8033]
Articles [64]
Editorials [9]
Conferences [214]
elearning [49]
ESMO 2016: MEK inhibition in KRAS-mutant NSCLC did not improve survival
ESMO 2016: MEK inhibition in KRAS-mutant NSCLC did not improve survival
ESMO 2016: Custirsen shows no survival benefits in metastatic prostate cancer
ESMO 2016: Custirsen shows no survival benefits in metastatic prostate cancer
A noninvasive approach may identify glioblastoma patients suitable for antiangiogenic therapy
A noninvasive approach may identify glioblastoma patients suitable for antiangiogenic therapy
ESMO 2016: Nintedanib improves PFS but not OS in phase III trial of metastatic colorectal cancer
ESMO 2016: Nintedanib improves PFS but not OS in phase III trial of metastatic colorectal cancer
ESMO 2016: Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify responders
ESMO 2016: Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify responders
ESMO 2016: Targeting oestrogen receptor improves progression-free survival in advanced breast cancer
ESMO 2016: Targeting oestrogen receptor improves progression-free survival in advanced breast cancer
ESMO 2016: Ribociclib improves progression-free survival in advanced breast cancer
ESMO 2016: Ribociclib improves progression-free survival in advanced breast cancer
ESMO 2016: Thousands of melanoma patients in Europe have no access to new drugs
ESMO 2016: Thousands of melanoma patients in Europe have no access to new drugs
ESMO 2016: Combination therapy shows higher response and lower toxicity in paediatric brain cancer trial
ESMO 2016: Combination therapy shows higher response and lower toxicity in paediatric brain cancer trial
IL-34 as a potential target to tackle drug-resistance
IL-34 as a potential target to tackle drug-resistance

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation